bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.08.11.744128

Ecological Network Inference Reveals 737 Cross-Kingdom Associations Structuring Human Microbiomes

Abstract

The human microbiome is a complex, multikingdom ecosystem where bacteria and fungi cohabit and interact. Despite their ecological and clinical significance, cross-kingdom dynamics remain poorly characterized due to dominant single-kingdom research approaches. To understand the principles structuring multi-kingdom microbial communities, we applied the sparse inference method SpiecEasi to 45 publicly available samples from the gastrointestinal tract, skin, and oral cavity. Bacterial (16S rRNA) and fungal (ITS) sequencing data were processed using QIIME2, managed in phyloseq, and co-occurrence networks were inferred via SpiecEasi with Meinshausen- Buhlmann estimation. To validate robustness, we employed SparCC as a secondary inference method and performed 100 bootstrap iterations. Body site stratification controlled for environmental confounders. Our analysis revealed a microbial network of 5,023 taxa (5,020 bacterial, 3 fungal) connected by 30,478 significant associations. Crucially, we identified 737 robust bacterial-fungal interkingdom interactions (689 positive, 48 negative) confirmed by both inference methods. The network exhibited sparse connectivity (density = 0.0024) and modular structure (modularity = 0.45). Hub analysis identified 15 keystone taxa, including Bacteroides uniformis and Faecalibacterium prausnitzii. Interaction patterns were body-site-specific (P < 0.001), with the gastrointestinal tract showing the highest interkingdom connectivity (385 edges). This study provides systematic evidence that bacterial-fungal interactions are abundant and integral to human microbiome architecture. The discovery of 737 cross-kingdom associations challenges the prevailing single-kingdom paradigm and advocates for an integrated multikingdom perspective. These interactions, particularly those mediated by keystone hubs, represent novel targets for microbiome-based therapeutics and diagnostics. ImportanceThis study challenges the prevailing single-kingdom paradigm in microbiome research by demonstrating that bacterial-fungal interactions are abundant and integral to human microbiome architecture. The discovery of 737 cross-kingdom associations across three body sites provides a foundational resource for understanding multikingdom microbial ecology. The identification of keystone bacterial hubs--particularly Bacteroides uniformis and Faecalibacterium prausnitzii--as central connectors in interkingdom networks opens new avenues for microbiome-based therapeutics and diagnostics. Our integrated analytical framework, combining SpiecEasi and SparCC with body site stratification, offers a robust methodological template for future cross-kingdom studies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Babaei, A., Siadat, S. D.. 2026-08-17. Ecological Network Inference Reveals 737 Cross-Kingdom Associations Structuring Human Microbiomes. https://doi.org/10.64898/2026.08.11.744128

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Reverse Transcription Loop-Mediated Isothermal Amplification Combined with Lateral Flow Assay (RT-LAMP-LFA) for Rapid Detection of the 2026 Bundibugyo Virus (BDBV) Outbreak Strain

Making accurate diagnosis is a critical first step in patient management and control for emerging and re-emerging disease outbreaks. Bundibugyo virus (BDBV) is a filovirus that causes Ebola disease, and the 2026 outbreak highlights the need for rapid diagnostic approaches that can be deployed in settings with limited laboratory infrastructure. Here, we developed a reverse transcription loop-mediated isothermal amplification-lateral flow assay (RT-LAMP-LFA) for rapid detection of the 2026 BDBV outbreak strain. LAMP primers were designed based on the genome sequence of the 2026 outbreak strain, and the conservation of the primer binding sites among all available 2026 outbreak genomes was confirmed in silico. LAMP primers were evaluated for analytical specificity and sensitivity using in vitro-transcribed RNA (ivtRNA) from BDBV and other filoviruses, as well as RNA derived from arboviruses and mammalian cells. Amplification products were detected using a Chromatography-Printed Array Strip (C-PAS) lateral flow platform. The newly designed primers specifically detected the presence of BDBV RNA without nonspecific amplification of the other viral or cellular RNA samples tested. Consistent amplification was observed down to 103 copies per reaction. In addition, BDBV viral RNA was successfully amplified, and the amplification products were detected using C-PAS, with the total workflow being completed within 25 min. These findings demonstrate the analytical specificity and sensitivity of the developed RT-LAMP-LFA assay and its compatibility with rapid visual lateral flow detection, supporting its potential application as a point-of-care approach for BDBV detection.

microbiology↗

Divergent methane production and microbial community responses to carbon enrichment in freshwater wetland sediments

Methane (CH4) accumulation in wetland sediments reflects interactions among organic matter, sediment chemistry, and microbial communities. We combined depth-resolved field characterization across four wetland habitats in northern Israel with complementary incubations to examine methane accumulation and responses to labile-carbon enrichment. Sediment cores were characterized using Rock-Eval analysis, porewater chemistry, oxygen profiling at three sites, and mcrA amplicon sequencing. High CH4 concentrations occurred under contrasting conditions: Ein Nimfit (EN) contained approximately 12% total organic carbon and reached 2.1 mM CH4, whereas Ein Afek site EA2 contained approximately 5% carbon and accumulated 0.7-1.7 mM CH4. Both showed sulfate depletion, but EN exhibited pronounced sulfide accumulation, whereas EA2 showed greater dissolved iron and nutrient enrichment. Their classified methanogenic assemblages also differed. EA1 remained methane poor despite increasing carbon content with depth, while EA3 combined low carbon content and CH4 accumulation with detectable methanogens and lower methanogenic diversity. In a 36-day bottle experiments using sediments from two of the four wetland habitats, sucrose-amended EA3 exhibited a transient maximum of 18.8 mmol collected CH4 kg-1 wet sediment during Days 22-29, whereas EN reached its highest collected amount during Days 29-36. Methane proportions increased before the large output increase in EA3 but remained comparatively stable and high in EN. Soluble chemical oxygen demand trajectories and microbial community changes also differed. These findings identify distinct biogeochemical settings supporting methane accumulation and demonstrate methanogenic potential in low-CH4 sediment, emphasizing the complementary information provided by field profiles, microbial characterization, and exploratory enrichment experiments.

microbiology↗

The absence of microbiome in germ-free mice exacerbates the pathogenicity of mouse-adapted SARS-CoV-2 MA10

Germ-free mice, which are devoid of microbiota, provide a powerful system to define the contribution of the microbiome to host responses during infection. Severe COVID-19 outcomes are associated with multiple comorbidities that are themselves characterized by microbiome dysbiosis; however, the causal role of the microbiota in SARS-CoV-2 pathogenesis remains poorly understood. Here, we use germ-free mouse models to evaluate the impact of the microbiome on disease severity following infection with mouse-adapted SARS-CoV-2 MA10. Comparison with conventionally housed mice revealed that the absence of the microbiome markedly exacerbates SARS-CoV-2-induced disease in both C57BL/6 and Swiss Webster backgrounds. Germ-free mice exhibited greater weight loss, impaired lung function, worsened pulmonary pathology, and pronounced alterations in circulating cytokine and chemokine profiles compared with conventional controls. These findings show that resident microbiota limit SARS-CoV-2 pathogenicity and establish germ-free COVID-19 models as a powerful platform to identify protective microbial taxa and microbiota-based interventions to reduce severe disease.

microbiology↗